CareCloud Reports Second Quarter 2026 Results

CareCloud, Inc. (CCLD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CareCloud Reports Second Quarter 2026 Results Revenue Grows 16%; Ninth Consecutive Quarter of Positive GAAP Net Income SOMERSET, N.J., August 6, 2026 (GLOBE NEWSWIRE)— CareCloud, Inc. (Nasdaq: CCLD), a leader in AI-powered healthcare technology and revenue cycle mana

Original reporting
Published Aug 6, 2026, 11:10 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 11:36 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CCLD
Bullish
medium confidence
Mentioned
$CCLD
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CCLDBullishMed
01

Why it matters

Near-term trading focus is likely on the reaffirmed FY 2026 revenue ($128-$132M), adjusted EBITDA ($29-$31M), and GAAP EPS ($0.20-$0.23), alongside the ninth consecutive quarter of positive GAAP net income and the Empower Healthcare acquisition entry into compliance and audit-defense.

02

Market read

This is a primary earnings and guidance update with specific quarterly performance and reiterated full-year targets, which can drive repricing around expectations for profitability and AI-driven cross-sell.

03

What to watch

The article highlights R&D and interest expense from capital structure simplification; traders may focus on whether adjusted EBITDA margin contraction continues into the back half of 2026.

Relevance 7/10Novelty 7/10Timing: pre-market/at filing time, Aug 6, 2026 (conference call at 8:30 a.m. ET)

Background

CareCloud filed an SEC 8-K with its Q2 2026 results and an attached earnings release (Exhibit 99.1), including a reaffirmation of 2026 outlook.

Company-level read

Ticker impact

$CCLDBullishMedium confidence
Context

CareCloud reported Q2 2026 revenue of $31.9M (+16% YoY), GAAP net income of $1.1M, and reaffirmed full-year 2026 guidance.

Expected impact

Likely supportive for the stock if the market focuses on the reaffirmed FY EPS range and the ninth consecutive quarter of positive GAAP net income.

Evidence & confidence

This is a primary-source earnings/guidance disclosure with specific quarterly and full-year numbers, but the article does not include consensus comparisons or any new guidance changes beyond reaffirmation.

Market effects

Reinforces demand for AI-enabled revenue cycle management and compliance/audit-defense offerings in healthcare IT, but impact is company-specific.

Limited, as the disclosure is for a single Nasdaq-listed issuer.

Low, healthcare RCM guidance is not a global macro driver.

Counterpoint

GAAP EPS was effectively $0.00 in Q2 and GAAP net income declined vs Q2 2025, so the market may discount the revenue growth if margins or cash flow do not follow.

Key entities

  • CareCloud, Inc.

    Nasdaq-listed healthcare technology and revenue cycle management provider reporting Q2 2026 results and reaffirming FY 2026 guidance.

  • Empower Healthcare & Compliance Partners

    Acquired to expand CareCloud’s compliance and audit-defense market entry and product portfolio.

Related articles

$CCLDHigh

CareCloud (CCLD) Q3 2026 Earnings Call Transcript

CareCloud (CCLD) reported record Q3 2026 earnings with revenue of $33.7M (+9% YoY), GAAP net income of $4.7M (+54% YoY), and EPS of $0.10. The company attributed growth to AI automation, expense discipline, and revenue mix shifts. It also completed a capital structure transformation, reducing preferred dividends by 86% and repaying debt. CareCloud highlighted growth engines like enterprise AI and compliance services, reaffirming its full-year outlook.

$CCLDMed

CareCloud Delivers Most Profitable Quarter in Company History: Record GAAP Net Income, Record GAAP EPS and Record adjusted EBITDA

CareCloud, Inc. (CCLD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NASDAQ: CCLD CareCloud Delivers Most Profitable Quarter in Company History: Record GAAP Net Income, Record GAAP EPS and Record adjusted EBITDA SOMERSET, N.J., November 5, 2026 (GLOBE NEWSWIRE) — CareCloud, Inc. (Nasdaq: CCLD) (“CareCloud” or the “Company”), a leader

$CCLDMedAI 8/10

CareCloud (CCLD) Q2 2026 Earnings Call Transcript

CareCloud (CCLD) reported Q2 2026 revenue of $31.9 million, up 16% year over year, mainly from the Medsphere acquisition. GAAP net income was $1.1 million, with breakeven GAAP EPS. Adjusted EBITDA was $5.9 million. The company redeemed $38.2 million of Series B preferred stock using a $50 million credit facility and reaffirmed FY2026 guidance: revenue $128-$132 million and adjusted EBITDA $29-$31 million.

Med

CareCloud, Inc. Q2 2026 Earnings Call Summary

CareCloud, Inc. reported 16% Q2 2026 revenue growth, citing Medsphere integration and a shift to recurring technology-enabled solutions at 75% of revenue. The company fully redeemed Series B preferred stock, removing about $3.3M annual dividends, and reaffirmed full-year 2026 guidance. It also acquired Empower Healthcare and Compliance Partners to expand into compliance and audit defense, and set a $60M ATM equity program.